A Single Center, Randomized, Interventional, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Lactoferrin Containing Cream In The Treatment Of Patients With Mild To Moderate Acne Vulgaris. - Nil

Frimline Private Limited0 个研究点目标入组 80 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. Male and Female patients with age 18 - 65 years, with acne vulgaris of face.
•2. Written informed consent signed by patient and willing to comply with the study procedure.
•3. Patients with mild to moderate acne, as determined by an Investigator Global Assessment (IGA) score of 2 to 3.
•4. Females of childbearing potential must have a negative pregnancy test at screening and agree to use an acceptable form of contraception during the study.

•1. Pregnant Lactating females.
•2. Previous hypersensitivity or allergic reaction to any of the components in the study medication.
•3. Patients with the skin conditions of the face such as open or incompletely healed wounds at the affected site or acute eczemas, rosacea, perioral dermatitis, atopic-seborrheic dermatitis or psoriasis.
•4. Use of topical acne medication within the past 1 weeks.
•5. Any significant dermatological condition or skin infection other than acne vulgaris that may interfere with the study assessments.
•6. Patients with the significant cardiovascular, hepatic, renal or any other systemic illnesses.
•7. Use of any Investigational drug or participation in another clinical trial within the past 30 days.
•8. Any other medical or psychological condition that, in the opinion of the investigator, may interfere with the patients ability to participate in the study or complete the study assessments.
•9. Any condition or situation that, in the investigators judgment, may put patient at risk or compromise the integrity of the study.

发起方

Frimline Private Limited